Immune-related gene expression profiles (GEPs) are tissue-agnostic measures of distinct aspects of tumor immunobiology and can predict either alone or in combination with TMB or PD-L1 expression the response to ICI therapy across multiple tumor types (Figure 3). Here, CD274 is linked to neoplasm.